FuturNet Communication logo — La vision du futur

FuturNet Communication

La vision du futur

Founded 2008 United Kingdom Nottingham, United Kingdom 1 employees Series Unknown Total: $3.90M Biopharma, Biotechnology

General Information

Company Name FuturNet Communication
Founded Year 2008
Location United Kingdom Nottingham, United Kingdom
Employees 1
Industries Biopharma, Biotechnology
Funding Stage Series Unknown
Social

Get notified when FuturNet Communication moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About FuturNet Communication

CompanDx Ltd is a Biopharma and Biotechnology company founded in 2008 and headquartered in the United Kingdom. The company specializes in unlocking the secrets of personalized medicine by leveraging in-house data analysis algorithms to identify patterns in healthcare data sets. CompanDx applies its technology to clinical trial and medical sample data to discover new disease markers, focusing on the identification of novel biomarkers accompanying the use of targeted therapies and companion diagnostics. The systematic application of technologies and mass spectrometry combined with Bioinformatics has enabled CompanDx to identify disease-specific biomarkers. The company also provides data mining services to proprietary repositories and monitors complete analysis of clinical trial databases. This focus is aimed at enabling effective disease management and reducing the risk of trial failure by patient stratification. CompanDx secured a £3.90M Venture Round investment on 31 July 2012. The investors involved in the last investment round are not specified. The company’s commitment to leveraging advanced technologies for personalized medicine and clinical trial analysis positions it as an innovative player in the biopharma and biotechnology sectors.

Taxonomy: personalized medicine, healthcare data, clinical trials, medical samples, biomarkers, targeted therapies, companion diagnostics, data mining, mass spectrometry, bioinformatics, patient stratification, disease management, trial failure, proprietary repositories

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 31 Jul 2012

FuturNet Communication Alternatives & Competitors

FuturNet Communication vs
VivoSense, Inc.
VivoSense, Inc. United States

Advancing clinical trials research and healthcare delivery with analytics & AI for all wearable sens...

Grant
42 employees
Biotechnology, Health Care
FuturNet Communication vs
Quant Biomarkers
Quant Biomarkers Switzerland

Quant Biomarkers is a data-driven biomedical and longevitytech company.

5 employees
Biotechnology, Marketing
FuturNet Communication vs
ClinFocus
ClinFocus United States

Clinical Data Management, Medical Monitoring, EDC Study Builders, SAS Programming, Data Analytics an...

48 employees
AI, Analytics

FAQ About FuturNet Communication

La vision du futur
FuturNet Communication was founded in 2008.
FuturNet Communication is headquartered in Nottingham, United Kingdom.
FuturNet Communication operates in the following industries: Biopharma, Biotechnology.
FuturNet Communication has approximately 1 employees.
FuturNet Communication has completed 1 funding round, raising a total of $3.90M. The latest funding stage is Series Unknown.
Top alternatives and competitors to FuturNet Communication include VivoSense, Inc., Quant Biomarkers , ClinFocus, Ovation, PlaqueTec Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
FuturNet Communication and VivoSense, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors FuturNet Communication and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes